Literature DB >> 2891414

Somatostatin centrally inhibits vasopressin secretion during haemorrhage.

X M Wang1, J J Tresham, M Congiu, J P Coghlan, B A Scoggins.   

Abstract

Somatostatin is a hypothalamic inhibiting factor which has been reported to be involved in the regulation of the secretion of several anterior pituitary hormones. To determine if somatostatin plays a role in the control of vasopressin secretion from the posterior pituitary, we examined the effects of intracerebroventricular infusion of somatostatin-14 and a super-active analogue, cyclo-(N-Me-Ala-Tyr-D-Trp-Lys-Val-Phe), on the concentration of plasma vasopressin in response to haemorrhage in conscious sheep. Haemorrhage (15 ml/kg over 15 min) elevated plasma vasopressin. Treatment with either somatostatin-14 or the analogue inhibited the elevation of plasma vasopressin induced by haemorrhage. The inhibition may result from an effect of somatostatin on neurotransmitter afferent inputs to the hypothalamus which trigger vasopressin release during haemorrhage. Our study demonstrates for the first time that somatostatin administered centrally inhibits vasopressin secretion during haemorrhage in the conscious animal.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891414     DOI: 10.1016/0006-8993(87)91577-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  1 in total

1.  Diabetes Insipidus Induced by Combination of Short-acting Octreotide and Lanreotide for Recurrent Carcinoid Crisis of Neuroendocrine Tumour: A Case Report.

Authors:  Goh Kian Guan; Subashini Rajoo; Noraini Mohd Dusa; Nik Hasimah Nik Yahya; Mohamed Badrulnizam Long Bidin
Journal:  J ASEAN Fed Endocr Soc       Date:  2021-08-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.